RE:THE LATEST COMPANY WHO HAS A PRICING SCANDAL
If I remember correctly, the 3 that are more expense are significantly more expense to tune of thousands more per dose. Even with price reductions, I'm not sure if they'll be sub $1K so the pricing pressure is there but not to the point where its very materially lower. Also, lower prices increases volumes so IMO, people who are using Donatel will continue to use it as the middle priced drug - if they're not willing to spend money for brands now, they won't when prices go down.